SBIR/STTR Research Award
Not Available
Award amount
$150,000Program and phase
SBIR · Phase IAward year
2010Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- SOLULINK BIOSCIENCES
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PHS2010-1
- Topic code
- NCI
Research abstract
The goal of this project is to develop multiple-biomarker imaging for detection of human papillomavirus (HPV) associated human cancer. Quantum dots (QDs) with multiple emission colors were chosen as optical probes to label the biomarkers on tissue. Attributeto the unique optical properties of QDs, they can be used as powerful cancer diagnostic tools providing the molecular profiles of cancer cases based on common clinical biopsies and allowing the tumor cell detection and analysis in highly heterogenous samples and rare cell populations. To develop practicable clinical products, several issues have to be solved, such as optical stability of fluorescence intensity of QDs under light irradiation, binding stability of QD-antibody conjugates on tissue during the staining process, imaging process method and optical readers. This SBIR team assembled material scientist, cancer biologist, pathologist, and imaging expert to address the key issues in the quantification of the expression level of HPV biomarker.
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Mini-reflectance confocal microscope (Mini-RCM) for aiding skin cancer diagnosis and treatment
- Development of small molecule therapeutics targeting AR-V7 for prostate cancer
- Decentralized Clinical Trial of Effectiveness of EnergyPoints App to Guide Acupressure Use for Fatigue and Sleep Disturbances in Cancer Survivors
- Optimized targeted radiotherapy of pancreatic cancer
- Adaptive imaging for pioneering multiplexed spatial profiling of tumors and tissues for cancer research and diagnosis